Lomond Therapeutics is based in Dover. It has raised $20M in total funding. Backed by Yosemite Management, QIA Investments, OrbiMed.
Lomond Therapeutics funding overview
Lomond Therapeutics is based in Dover. Lomond Therapeutics has raised $20M in total disclosed funding. That places its disclosed total in the $1M–$25M range. The round record for Lomond Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Yosemite Management, QIA Investments, OrbiMed, Torrey Pines Investment. 4 distinct backers are named across the disclosed rounds.
Frequently asked about Lomond Therapeutics funding
How much has Lomond Therapeutics raised?
Lomond Therapeutics has raised $20M in total disclosed funding across the rounds on record.
Who has invested in Lomond Therapeutics?
Yosemite Management, QIA Investments, OrbiMed, Torrey Pines Investment are named among the investors backing Lomond Therapeutics.
What was the latest Lomond Therapeutics funding round?
No round stage has been disclosed for Lomond Therapeutics.
Where is Lomond Therapeutics based?
Lomond Therapeutics is based in Dover.
When did Lomond Therapeutics last raise?
The last disclosed Lomond Therapeutics round closed in March 2025.
Round data for Lomond Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Dover and backer lists below.
